A detailed history of Farther Finance Advisors, LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 2 shares of LUNG stock, worth $13. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$13
Previous $12,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$5.77 - $9.82 $11 - $19
-2 Reduced 50.0%
2 $12,000
Q1 2024

May 13, 2024

SELL
$8.71 - $14.65 $357 - $600
-41 Reduced 91.11%
4 $37,000
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $355 - $591
45 New
45 $574,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $256M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.